Clik here to view.
Health Risk-Management: The value of real-time monitoring of body chemistries
We are becoming more accustomed to continually tracking health metrics with smart wearable devices. The next step will be implantable devices, which provide real-time monitoring of body chemistry....
View ArticleClik here to view.
Injectable Body Sensors Take Personal Chemistry to a Cell Phone Closer to...
Editor’s Note: The American Chemical Society is also issuing a press release today embargoed for 5am Eastern Time that can be requested at newsroom@acs.org or call 504-670-6721. NEW ORLEANS, March 19,...
View ArticleClik here to view.
Potential Utility of Tissue Oxygen Sensors in Perfusion Monitoring
Novel microsensing technology that reflects microvascular perfusion and oxygen supply in tissue shows promise in patients with chronic limb-threatening ischemia. By Miguel Montero-Baker, MD; Arne...
View ArticleClik here to view.
Profusa Closes $45 Million Series C Financing
Leading global investors join this round; financing will accelerate commercialization of Lumee Oxygen Platform and pioneering glucose biosensors South San Francisco, Calif. – August 14, 2018 – Profusa,...
View ArticleProfusa to Present at DARPA D60 Symposium
Profusa Software and Systems Lead, Kevin Zhao, has been selected to participate in the Defense Advanced Research Projects Agency’s (DARPA) 60th Anniversary Symposium (D60) as a DARPA Riser. The D60...
View ArticleClik here to view.
Profusa Recognized by Frost & Sullivan For Innovation in the Biochemical...
Awarded 2018 Entrepreneurial Company of the Year for real-time body chemistry monitoring South San Francisco, Calif. – October 15, 2018 – Profusa, a company dedicated to the development of...
View ArticleProfusa Receives CE Mark Approval to Market the Wireless Lumee® Oxygen...
Next-Generation Wireless Device May Enable Telehealth And Remote Patient Monitoring in the Future EMERYVILLE, Calif., [January 28, 2020] – Profusa, a digital health company that is pioneering the next...
View ArticleResearch Presented at LINC Suggests the Profusa Lumee® Oxygen Platform May...
New Insights Come as Profusa Receives CE Mark for Its Latest Generation Device, the Wireless Lumee® Oxygen Platform LEIPZIG, Germany, and EMERYVILLE, Calif., [January 30, 2020] – Profusa, a digital...
View ArticleProfusa and Partners Announce Initiation of Study to Measure Early Signs of...
DARPA-Backed Study Leverages Profusa’s Lumee® Oxygen Platform as Part of a Larger Effort to Speed Detection and Predict Disease Outbreaks EMERYVILLE, Calif., March 3, 2020 – Profusa, a digital health...
View Article
